Abbott Laboratories agreed to settle claims from a laid-off worker that the company engaged in pregnancy discrimination by ...
Shares of Abbott Laboratories ABT inched 0.39% higher to $114.76 Tuesday, on what proved to be an all-around positive trading ...
Abbott Laboratories and DexCom said on Monday they have reached an agreement to settle all patent disputes between them ...
Abbott is one of the biggest healthcare companies in the world. With over 400 consecutive quarterly dividend payouts and 53 ...
Abbott Laboratories is rated a Buy due to growth indicators, diversified portfolio, strong profit margin. Read an investment ...
Abbott Laboratories (ABT) stock saw a modest uptick, ending the day at $114.23 which represents a slight increase of $1.81 or 1.61% from the prior close of $112.42. The stock opened at $112.64 and ...
A federal appeals court trimmed a whistleblower’s once-defeated False Claims Act suit Friday alleging Abbott Laboratories Inc ...
M&T Bank Corp lessened its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 6.3% during the 3rd quarter, ...
Wells Fargo notes Abbott (ABT) and DexCom (DXCM) have disclosed that on December 20, they settled and entered into a cross-license agreement to ...
As previously disclosed, DexCom has been involved in global patent litigation with Abbott Diabetes Care and its affiliates. Both the Comp ...
The main point of investing for the long term is to make money. But more than that, you probably want to see it ...
Abbott Laboratories (ABT) stock saw a modest uptick, ending the day at $112.42 which represents a slight increase of $0.49 or 0.44% from the prior close of $111.93. The stock opened at $111.54 and ...